Twist Bioscience Corporation
TWST
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital dā¦ read more
Healthcare
Diagnostics & Research
7 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$33.65
Price-4.02%
-$1.41
1Y
Price
Market Cap
$2.013b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-21.1%
EBITDA Margin-27.4%
Net Profit Margin-24.5%
Free Cash Flow MarginRevenue
$376.572m
+20.3%
1y CAGR+22.8%
3y CAGR+30.6%
5y CAGREarnings
-$77.670m
+62.8%
1y CAGR+22.3%
3y CAGR+5.9%
5y CAGREPS
-$1.31
+63.6%
1y CAGR+24.8%
3y CAGR+11.6%
5y CAGRBook Value
$472.958m
$641.861m
Assets$168.903m
Liabilities$75.572m
DebtDebt to Assets
11.8%
-1.4x
Debt to EBITDAFree Cash Flow
-$75.632m
-9.3%
1y CAGR+24.9%
3y CAGR+3.1%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company